501 - Oral Abstract Session
Antibody-Mediated Rejection 2 (Videos Available)

Wednesday July 04, 2018 | 08:30 to 09:30
Room: N-102
Track: Kidney


Prof. Carmen Lefaucheur, France
Anti-angiotensin II type 1-receptor antibodies (AT1R-Ab) induce a specific phenotype of rejection distinct from HLA antibody-mediated rejection

Dr. Carrie A Schinstock, United States
Banff survey on antibody mediated injury in kidney allografts: Diagnostic misclassification affects the treatment approach

Prof. Handan Ozdemir, Turkey
Rearrangement of the endothelial cell cytoskeleton in glomerular and peritubular capillaries (PTCS) following antibody-mediated rejection (AMR): Its significance on the development of transplant glomerulopathy and interstitial fibrosis

Hon. Marek Novotny, Czech Republic
Intimal arteritis associated with microvascular inflammation even in the absence of donor-specific antibodies might result into early chronic rejection

Dr. Janka Slatinska, Czech Republic
Do C1q-positive donor specific antibodies have prognostic effect in patients with resistant antibody-mediated rejection treated with bortezomib? Single-centre experience (Video Available)

© 2021 TTS2018